Exclusive

Publication

Byline

Location

US Patent Issued to Gdanski Uniwersytet Medyczny on Oct. 27 for "Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying Treg cells to produce therapeutic vaccine for treatment of diabetes type 1" (Polish Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,444, issued on Oct. 27, was assigned to Gdanski Uniwersytet Medyczny (Gdansk, Poland). "Therapeutic vaccine for treatment of diabetes type ... Read More


US Patent Issued to Health Research on Oct. 27 for "Major histocompatibility complex class II-expressing cancer cell vaccine and methods of use for producing integrated immune responses" (New York Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,445, issued on Oct. 27, was assigned to Health Research Inc. (Buffalo, N.Y.). "Major histocompatibility complex class II-expressing cancer ... Read More


US Patent Issued to STEMCELL TECHNOLOGIES CANADA on Oct. 27 for "Methods to stimulate immune responses to mutant Ras using nucleated cells" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,446, issued on Oct. 27, was assigned to STEMCELL TECHNOLOGIES CANADA INC. (Vancouver, Canada). "Methods to stimulate immune responses to mu... Read More


US Patent Issued to Pfizer on Oct. 27 for "Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof" (North Carolina, New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,447, issued on Oct. 27, was assigned to Pfizer Inc. (New York). "Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and ... Read More


US Patent Issued to Merck Sharp & Dohme on Oct. 27 for "Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,448, issued on Oct. 27, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Compositions comprising Streptococcus pneumoniae polysacch... Read More


US Patent Issued to The Catholic University of America on Oct. 27 for "Bacteriophage-based, needle and adjuvant-free, mucosal COVID-19 vaccine" (District Of Columbia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,449, issued on Oct. 27, was assigned to The Catholic University of America (Washington). "Bacteriophage-based, needle and adjuvant-free, mu... Read More


US Patent Issued to EMORY UNIVERSITY on Oct. 27 for "Coronavirus vaccines, compositions, and methods related thereto" (Georgia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,450, issued on Oct. 27, was assigned to EMORY UNIVERSITY (Atlanta). "Coronavirus vaccines, compositions, and methods related thereto" was i... Read More


US Patent Issued to University of Florida Research Foundation on Oct. 27 for "Methods of tolerizing a subject to a viral vector" (Florida Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,451, issued on Oct. 27, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Methods of tolerizing a subjec... Read More


US Patent Issued to TCR2 THERAPEUTICS on Oct. 27 for "Compositions and methods for TCR reprogramming using CD70 specific fusion proteins" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,452, issued on Oct. 27, was assigned to TCR2 THERAPEUTICS INC. (Cambridge, Mass.). "Compositions and methods for TCR reprogramming using CD... Read More


US Patent Issued on Oct. 27 for "Fluorescent systems for biological imaging and uses thereof" (British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,453, issued on Oct. 27. "Fluorescent systems for biological imaging and uses thereof" was invented by Andrew Whiting (Wynyard Billingham Du... Read More